{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T04:59:38Z","timestamp":1787029178137,"version":"build-2736575974"},"reference-count":40,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2022,2,5]],"date-time":"2022-02-05T00:00:00Z","timestamp":1644019200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nutrients"],"abstract":"<jats:p>Iron deficiency (ID) diagnosis in cystic fibrosis (CF) is challenging because of frequent systemic inflammation. We aimed to determine the prevalence and risk factors of ID in adult patients with CF. We conducted a single-centre prospective study in a referral centre. ID was defined by transferrin saturation \u226416% or ferritin \u226420 (women) or 30 (men) \u03bcg\/L, or \u2264100 \u03bcg\/L in the case of systemic inflammation. Apparent exacerbation was an exclusion criterion. We included 165 patients (78 women), mean age\u201431.1 \u00b1 8.9 years. ID prevalence was 44.2%. ID was significantly associated with female gender (58.9% vs. 38%), lower age (29.4 \u00b1 8.5 vs. 32.5 \u00b1 9.1), lower body mass index (20.5 \u00b1 2.2 vs. 21.3 \u00b1 2.5), and Pseudomonas aeruginosa colonization (70.8% vs. 55.1%). Diabetes mellitus, antiacid drug use and low pulmonary function were more frequent in patients with ID with no statistical significance. The use of CFTR correctors was not associated with ID. In the multivariate analysis, ID was associated with female gender (OR 2.64, CI95% 1.31\u20135.31), age &lt; 30 years (OR 2.30, CI95% 1.16\u20134.56), and P. aeruginosa (OR 2.09, CI95% 1.04\u20134.19).<\/jats:p>","DOI":"10.3390\/nu14030673","type":"journal-article","created":{"date-parts":[[2022,2,6]],"date-time":"2022-02-06T20:38:40Z","timestamp":1644179920000},"page":"673","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Iron Deficiency in Cystic Fibrosis: A Cross-Sectional Single-Centre Study in a Referral Adult Centre"],"prefix":"10.3390","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8511-8432","authenticated-orcid":false,"given":"Herv\u00e9","family":"Lobbes","sequence":"first","affiliation":[{"name":"Service de M\u00e9decine Interne, H\u00f4pital Estaing, CHU de Clermont-Ferrand, F-63000 Clermont-Ferrand, France"},{"name":"SIGMA Clermont, Institut Pascal, CHU Clermont-Ferrand, Universit\u00e9 Clermont Auvergne, CNRS, F-63000 Clermont-Ferrand, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"St\u00e9phane","family":"Durupt","sequence":"additional","affiliation":[{"name":"D\u00e9partement de M\u00e9decine Interne et Centre de R\u00e9f\u00e9rence Mucoviscidose, Centre Hospitalier Lyon Sud, Hospices Civils de Lyon, F-69310 Pierre-B\u00e9nite, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabine","family":"Mainbourg","sequence":"additional","affiliation":[{"name":"D\u00e9partement de M\u00e9decine Interne et Centre de R\u00e9f\u00e9rence Mucoviscidose, Centre Hospitalier Lyon Sud, Hospices Civils de Lyon, F-69310 Pierre-B\u00e9nite, France"},{"name":"Equipe Evaluation et Mod\u00e9lisation des Effets Th\u00e9rapeutiques, UMR 5558, Laboratoire de Biom\u00e9trie et Biologie Evolutive, CNRS, Claude Bernard University Lyon 1, F-69622 Villeurbanne, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3778-7161","authenticated-orcid":false,"given":"Bruno","family":"Pereira","sequence":"additional","affiliation":[{"name":"Biostatistics Unit, Centre Hospitalier Universitaire de Clermont-Ferrand, F-63000 Clermont-Ferrand, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raphaele","family":"Nove-Josserand","sequence":"additional","affiliation":[{"name":"D\u00e9partement de M\u00e9decine Interne et Centre de R\u00e9f\u00e9rence Mucoviscidose, Centre Hospitalier Lyon Sud, Hospices Civils de Lyon, F-69310 Pierre-B\u00e9nite, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3874-5580","authenticated-orcid":false,"given":"Isabelle","family":"Durieu","sequence":"additional","affiliation":[{"name":"D\u00e9partement de M\u00e9decine Interne et Centre de R\u00e9f\u00e9rence Mucoviscidose, Centre Hospitalier Lyon Sud, Hospices Civils de Lyon, F-69310 Pierre-B\u00e9nite, France"},{"name":"Research on Healthcare Performance (REHSAPE), INSERM U1290, Universit\u00e9 Claude Bernard Lyon 1, F-69373 Lyon, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quitterie","family":"Reynaud","sequence":"additional","affiliation":[{"name":"D\u00e9partement de M\u00e9decine Interne et Centre de R\u00e9f\u00e9rence Mucoviscidose, Centre Hospitalier Lyon Sud, Hospices Civils de Lyon, F-69310 Pierre-B\u00e9nite, France"},{"name":"Research on Healthcare Performance (REHSAPE), INSERM U1290, Universit\u00e9 Claude Bernard Lyon 1, F-69373 Lyon, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,2,5]]},"reference":[{"key":"ref_1","unstructured":"GBD (2018). 2017 Disease and Injury Incidence and Prevalence Collaborators Global, Regional, and National Incidence, Prevalence, and Years Lived with Disability for 354 Diseases and Injuries for 195 Countries and Territories, 1990-2017: A Systematic Analysis for the Global Burden of Disease Study 2017. Lancet, 392, 1789\u20131858."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1002\/ppul.20717","article-title":"Lung Disease Severity, Chronic Inflammation, Iron Deficiency, and Erythropoietin Response in Adults with Cystic Fibrosis","volume":"42","author":"Fischer","year":"2007","journal-title":"Pediatric Pulmonol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1164\/rccm.201312-2142OC","article-title":"Conditions Associated with the Cystic Fibrosis Defect Promote Chronic Pseudomonas Aeruginosa Infection","volume":"189","author":"Staudinger","year":"2014","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1183\/09031936.00124012","article-title":"Targeting Iron Uptake to Control Pseudomonas Aeruginosa Infections in Cystic Fibrosis","volume":"42","author":"Smith","year":"2013","journal-title":"Eur. Respir. J."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1258\/0004563001899708","article-title":"Assessment of Iron Status in Cystic Fibrosis Patients","volume":"37","author":"Keevil","year":"2000","journal-title":"Ann. Clin. Biochem."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1378\/chest.121.1.48","article-title":"Iron Deficiency in Cystic Fibrosis: Relationship to Lung Disease Severity and Chronic Pseudomonas Aeruginosa Infection","volume":"121","author":"Reid","year":"2002","journal-title":"Chest"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1002\/ppul.22857","article-title":"Iron Deficiency Occurs Frequently in Children with Cystic Fibrosis","volume":"49","author":"Uijterschout","year":"2014","journal-title":"Pediatric Pulmonol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1177\/0884533608323426","article-title":"Anemia in Cystic Fibrosis: Incidence, Mechanisms, and Association with Pulmonary Function and Vitamin Deficiency","volume":"23","author":"Biller","year":"2008","journal-title":"Nutr. Clin. Pract."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.jcf.2012.10.001","article-title":"Accurate Assessment of Systemic Iron Status in Cystic Fibrosis Will Avoid the Hazards of Inappropriate Iron Supplementation","volume":"12","author":"Smith","year":"2013","journal-title":"J. Cyst. Fibros."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1002\/ncp.10454","article-title":"Prevalence and Risk Factors for Iron Deficiency in Adults With Cystic Fibrosis","volume":"35","author":"Gettle","year":"2020","journal-title":"Nutr. Clin. Pract."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1182\/blood-2018-05-815944","article-title":"Iron Deficiency","volume":"133","author":"Camaschella","year":"2019","journal-title":"Blood"},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Nemeth, E., and Ganz, T. (2021). Hepcidin-Ferroportin Interaction Controls Systemic Iron Homeostasis. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22126493"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1056\/NEJM199409083311003","article-title":"Effect of Aerosolized Recombinant Human DNase on Exacerbations of Respiratory Symptoms and on Pulmonary Function in Patients with Cystic Fibrosis. The Pulmozyme Study Group","volume":"331","author":"Fuchs","year":"1994","journal-title":"N. Engl. J. Med."},{"key":"ref_14","unstructured":"World Health Organization (2011). Haemoglobin Concentrations for the Diagnosis of Anaemia and Assessment of Severity, World Health Organization."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1136\/adc.62.2.185","article-title":"Iron Deficiency in Cystic Fibrosis","volume":"62","author":"Ehrhardt","year":"1987","journal-title":"Arch. Dis. Child."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.cca.2006.11.021","article-title":"The Use of Soluble Transferin Receptor to Assess Iron Deficiency in Adults with Cystic Fibrosis","volume":"378","author":"Khalid","year":"2007","journal-title":"Clin. Chim. Acta"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"e94217","DOI":"10.1371\/journal.pone.0094217","article-title":"Evaluation of a Single Dose of Ferric Carboxymaltose in Fatigued, Iron-Deficient Women\u2014PREFER a Randomized, Placebo-Controlled Study","volume":"9","author":"Favrat","year":"2014","journal-title":"PLoS ONE"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1056\/NEJMra070553","article-title":"Vitamin D Deficiency","volume":"357","author":"Holick","year":"2007","journal-title":"N. Engl. J. Med."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1017\/S000711451500272X","article-title":"Vitamin E Function and Requirements in Relation to PUFA","volume":"114","author":"Raederstorff","year":"2015","journal-title":"Br. J. Nutr."},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Carazo, A., Mac\u00e1kov\u00e1, K., Matou\u0161ov\u00e1, K., Kr\u010dmov\u00e1, L.K., Protti, M., and Mlad\u011bnka, P. (2021). Vitamin A Update: Forms, Sources, Kinetics, Detection, Function, Deficiency, Therapeutic Use and Toxicity. Nutrients, 13.","DOI":"10.3390\/nu13051703"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"573","DOI":"10.7326\/0003-4819-147-8-200710160-00010","article-title":"STROBE Initiative The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: Guidelines for Reporting Observational Studies","volume":"147","author":"Altman","year":"2007","journal-title":"Ann. Intern. Med."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.2215\/CJN.01490506","article-title":"Assessing Iron Status: Beyond Serum Ferritin and Transferrin Saturation","volume":"1","author":"Wish","year":"2006","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"ref_23","first-page":"9394060","article-title":"Limitations of Serum Ferritin in Diagnosing Iron Deficiency in Inflammatory Conditions","volume":"2018","author":"Dignass","year":"2018","journal-title":"Int. J. Chronic. Dis."},{"key":"ref_24","first-page":"3040346","article-title":"Serum Hepcidin Level as a Marker of Iron Status in Children with Cystic Fibrosis","volume":"2018","year":"2018","journal-title":"Mediat. Inflamm."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1038\/pr.2014.30","article-title":"Evaluation of Micronutrient Profile of North Indian Children with Cystic Fibrosis: A Case\u2013Control Study","volume":"75","author":"Yadav","year":"2014","journal-title":"Pediatr. Res."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1111\/j.1752-8062.2012.00417.x","article-title":"Iron Homeostasis during Cystic Fibrosis Pulmonary Exacerbation","volume":"5","author":"Gifford","year":"2012","journal-title":"Clin. Transl. Sci."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1002\/ppul.21335","article-title":"Iron and CF-Related Anemia: Expanding Clinical and Biochemical Relationships","volume":"46","author":"Gifford","year":"2011","journal-title":"Pediatr. Pulmonol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1136\/adc.87.6.518","article-title":"Are Annual Blood Tests in Preschool Cystic Fibrosis Patients Worthwhile?","volume":"87","author":"Buchdahl","year":"2002","journal-title":"Arch. Dis. Child."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/S0954-6111(96)90114-6","article-title":"Functional Iron Deficiency in Adults with Cystic Fibrosis","volume":"90","author":"Pond","year":"1996","journal-title":"Respir. Med."},{"key":"ref_30","first-page":"969","article-title":"Effect of Pancreatic Enzyme Supplements on Iron Absorption","volume":"143","author":"Zempsky","year":"1989","journal-title":"Am. J. Dis. Child."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1542\/peds.71.5.810","article-title":"Relative Anemia and Iron Deficiency in Cystic Fibrosis","volume":"71","author":"Ater","year":"1983","journal-title":"Pediatrics"},{"key":"ref_32","unstructured":"(2002). Centers for Disease Control and Prevention (CDC) Iron Deficiency--United States, 1999-2000. MMWR Morb. Mortal. Wkly. Rep., 51, 897\u2013899."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"2003502","DOI":"10.1183\/13993003.03502-2020","article-title":"Targeting Cystic Fibrosis Inflammation in the Age of CFTR Modulators: Focus on Macrophages","volume":"57","author":"Gillan","year":"2021","journal-title":"Eur. Respir. J."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1513\/AnnalsATS.201807-449OC","article-title":"CFTR Modulator Use Is Associated with Higher Hemoglobin Levels in Individuals with Cystic Fibrosis","volume":"16","author":"Gifford","year":"2019","journal-title":"Ann. Am. Thorac. Soc."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1002\/ppul.24323","article-title":"Perspectives on Anemia and Iron Deficiency from the Cystic Fibrosis Care Community","volume":"54","author":"Garlow","year":"2019","journal-title":"Pediatr. Pulmonol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/j.jcf.2012.05.002","article-title":"Intravenous Iron among Cystic Fibrosis Patients","volume":"11","author":"Hoo","year":"2012","journal-title":"J. Cyst. Fibros."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.jcf.2013.11.004","article-title":"Iron Supplementation Does Not Worsen Respiratory Health or Alter the Sputum Microbiome in Cystic Fibrosis","volume":"13","author":"Gifford","year":"2014","journal-title":"J. Cyst. Fibros."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1002\/ajh.24461","article-title":"Intravenous Iron Therapy in Non-Anemic Iron-Deficient Menstruating Adolescent Females with Fatigue","volume":"91","author":"Sharma","year":"2016","journal-title":"Am. J. Hematol."},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Jankowska, E.A., Kirwan, B.-A., Kosiborod, M., Butler, J., Anker, S.D., McDonagh, T., Dorobantu, M., Drozdz, J., Filippatos, G., and Keren, A. (2021). The Effect of Intravenous Ferric Carboxymaltose on Health-Related Quality of Life in Iron-Deficient Patients with Acute Heart Failure: The Results of the AFFIRM-AHF Study. Eur. Heart J., ehab234.","DOI":"10.1093\/eurheartj\/ehab234"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.clnu.2016.03.004","article-title":"ESPEN-ESPGHAN-ECFS Guidelines on Nutrition Care for Infants, Children, and Adults with Cystic Fibrosis","volume":"35","author":"Turck","year":"2016","journal-title":"Clin. Nutr."}],"container-title":["Nutrients"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6643\/14\/3\/673\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T22:14:30Z","timestamp":1760134470000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6643\/14\/3\/673"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,5]]},"references-count":40,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2022,2]]}},"alternative-id":["nu14030673"],"URL":"https:\/\/doi.org\/10.3390\/nu14030673","relation":{},"ISSN":["2072-6643"],"issn-type":[{"value":"2072-6643","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,5]]}}}